These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interferon for hepatitis C patients with psychiatric disorders. Rifai MA; Bozorg B; Rosenstein DL Am J Psychiatry; 2004 Dec; 161(12):2331-2; author reply 2332-4. PubMed ID: 15569919 [No Abstract] [Full Text] [Related]
3. Treatment duration for genotypes 2 and 3: still confusing after all these years. Jensen DM J Clin Gastroenterol; 2010 Sep; 44(8):527-8. PubMed ID: 20628314 [No Abstract] [Full Text] [Related]
4. A change of peginterferon may permit continuation of antiviral therapy in hepatitis C virus-infected patients with interstitial pneumonitis. Shimada M; Yoshida S; Kornek M; Kim SJ; Schuppan D Liver Int; 2010 Nov; 30(10):1552-4. PubMed ID: 20557455 [No Abstract] [Full Text] [Related]
5. [Antiviral therapy of patients with chronic hepatitis C with normal level of aminotransferases]. Lopukhova NL Eksp Klin Gastroenterol; 2007; (4):146-52. PubMed ID: 18409502 [No Abstract] [Full Text] [Related]
6. [Peginterferon-alfa-2b or -alfa-2a and ribavirin combined treatment in hepatitis C infection]. Szalay F Orv Hetil; 2010 Feb; 151(7):271-3. PubMed ID: 20133247 [No Abstract] [Full Text] [Related]
7. Predicting treatment outcome following 24 weeks peginterferon alpha-2a/ribavirin therapy in patients infected with HCV genotype 1: utility of HCV-RNA at day 0, day 22, day 29, and week 6. Lukasiewicz E; Hellstrand K; Westin J; Ferrari C; Neumann AU; Pawlotsky JM; Schalm SW; Zeuzem S; Veldt BJ; Hansen BE; Verhey-Hart E; Lagging M Hepatology; 2007 Jan; 45(1):258-9. PubMed ID: 17187414 [No Abstract] [Full Text] [Related]
8. Pegylated IFN-alpha2a and ribavirin in the treatment of hepatitis C. Aghemo A; Rumi MG; Colombo M Expert Rev Anti Infect Ther; 2009 Oct; 7(8):925-35. PubMed ID: 19803700 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis C treatment, HAART and side effects. TreatmentUpdate; 2001; 13(7):7-8. PubMed ID: 11794865 [No Abstract] [Full Text] [Related]
10. Peginterferon and ribavirin for chronic hepatitis C. Hoofnagle JH; Seeff LB N Engl J Med; 2006 Dec; 355(23):2444-51. PubMed ID: 17151366 [No Abstract] [Full Text] [Related]
11. Results of a study of prolonging treatment with pegylated interferon-alpha2a plus ribavirin in HIV/HCV-coinfected patients with no early virological response. Fuster D; Planas R; Gonzalez J; Force L; Cervantes M; Vilaró J; Roget M; García I; Pedrol E; Tor J; Ballesteros AL; Salas A; Sirera G; Videla S; Clotet B; Tural C Antivir Ther; 2006; 11(4):473-82. PubMed ID: 16856621 [TBL] [Abstract][Full Text] [Related]
18. Catatonia associated with pegylated interferon-α 2b and ribavirin for hepatitis C. Quinn D; Kuchler E; Deming P; Arora S Psychosomatics; 2012; 53(4):400-1. PubMed ID: 22748752 [No Abstract] [Full Text] [Related]
19. Peginterferon alpha-2a (40 KD) plus ribavirin for the treatment of chronic hepatitis C in Japanese patients. Kuboki M; Iino S; Okuno T; Omata M; Kiyosawa K; Kumada H; Hayashi N; Sakai T J Gastroenterol Hepatol; 2007 May; 22(5):645-52. PubMed ID: 17444850 [TBL] [Abstract][Full Text] [Related]
20. HCV findings presented at EASL: long-term follow-up and the criteria of a cure. Lang L Gastroenterology; 2007 Jun; 132(7):2282-3. PubMed ID: 17570197 [No Abstract] [Full Text] [Related] [Next] [New Search]